SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Thursday reported a loss of $134.4 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.12.
The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.34 per share.
The biopharmaceutical company posted revenue of $66.8 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $3.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
